Oruka Therapeutics, Inc. ORKA Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayable.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s change in other liabilities?
- Oruka Therapeutics, Inc. (ORKA) reported change in other liabilities of -$493K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s change in other liabilities changed year-over-year?
- Oruka Therapeutics, Inc.'s change in other liabilities decreased by 694.0% year-over-year, from $83K to -$493K.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.